We are translating our innovation in targeted delivery to RNA therapeutics
for improving life quality of patients.
| Target | Indication | Discovery | Preclinical | Phase l |
|---|---|---|---|---|
| T cells | Systemic lupus erythematosus (SLE) | |||
| HSC | Undisclosed | |||
| CNS | Undisclosed |







